Table 1 Correlation between the clinicopathological characteristics and expression of miR-32-5p and PTEN in HCC patients
Characteristics |  | Number of patients | miR-32-5p expression (Mean ± SEM) | PTEN expression (Mean ± SEM) |
|---|---|---|---|---|
Age | < 50 | 22 | 210.20 ± 54.50 | 6.15 ± 2.59 |
|  | > 50 | 22 | 269.50 ± 51.36 | 1.34 ± 0.59 |
Sex | Male | 37 | 262.59 ± 42.58 | 4.31 ± 1.60 |
|  | Female | 7 | 119.65 ± 47.41 | 0.73 ± 0.57 |
TNM Stage | I + II | 19 | 142.32 ± 37.58* | 7.20 ± 2.956* |
|  | III + IV | 25 | 314.00 ± 55.21* | 1.11 ± 0.47* |
Tumor size | < 5 cm | 13 | 252.46 ± 64.51 | 1.74 ± 0.76 |
|  | > 5 cm | 24 | 198.01 ± 44.21 | 4.68 ± 1.96 |
Death | Alive | 19 | 5.74 ± 0.63*** | 8.24 ± 2.88* |
|  | Dead | 25 | 310.04 ± 52.32*** | 0.32 ± 0.13* |
HBV infection | No | 3 | 562.55 ± 124.12 | 0.07 ± 0.02 |
|  | Yes | 41 | 216.24 ± 36.64 | 4.01 ± 1.46 |
AFP | < 40 | 9 | 200.29 ± 79.81 | 13.26 ± 5.67 |
|  | > 40 | 35 | 250.02 ± 42.54 | 3.74 ± 1.36 |
Complications | Yes | 9 | 251.26 ± 82.66 | 2.21 ± 1.13 |
|  | No | 36 | 239.31 ± 41.25 | 11.39 ± 7.44 |